These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 20331961)

  • 1. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.
    Lin ME; Herr DR; Chun J
    Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):130-8. PubMed ID: 20331961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
    Hama K; Aoki J
    Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPA receptors: subtypes and biological actions.
    Choi JW; Herr DR; Noguchi K; Yung YC; Lee CW; Mutoh T; Lin ME; Teo ST; Park KE; Mosley AN; Chun J
    Annu Rev Pharmacol Toxicol; 2010; 50():157-86. PubMed ID: 20055701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPA receptor signaling: pharmacology, physiology, and pathophysiology.
    Yung YC; Stoddard NC; Chun J
    J Lipid Res; 2014 Jul; 55(7):1192-214. PubMed ID: 24643338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
    Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
    Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Control of Lysophosphatidic Acid Signaling.
    Morstein J; Dacheux MA; Norman DD; Shemet A; Donthamsetti PC; Citir M; Frank JA; Schultz C; Isacoff EY; Parrill AL; Tigyi GJ; Trauner D
    J Am Chem Soc; 2020 Jun; 142(24):10612-10616. PubMed ID: 32469525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analyses of lysophosphatidic acid receptor-mediated signaling.
    Fukushima N; Ishii S; Tsujiuchi T; Kagawa N; Katoh K
    Cell Mol Life Sci; 2015 Jun; 72(12):2377-94. PubMed ID: 25732591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
    Balijepalli P; Sitton CC; Meier KE
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
    Lin ME; Rivera RR; Chun J
    J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid receptors in cancer pathobiology.
    Tsujiuchi T; Araki M; Hirane M; Dong Y; Fukushima N
    Histol Histopathol; 2014 Mar; 29(3):313-21. PubMed ID: 24194373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.
    Ye X; Chun J
    Trends Endocrinol Metab; 2010 Jan; 21(1):17-24. PubMed ID: 19836970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lysophosphatidic acid and its receptors in the kidney.
    Park F; Miller DD
    Physiol Genomics; 2017 Nov; 49(11):659-666. PubMed ID: 28939644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Druggable Lysophospholipid Signaling Pathways.
    Yanagida K; Valentine WJ
    Adv Exp Med Biol; 2020; 1274():137-176. PubMed ID: 32894510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
    Li G; Mosier PD; Fang X; Zhang Y
    J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.
    Tigyi GJ; Johnson LR; Lee SC; Norman DD; Szabo E; Balogh A; Thompson K; Boler A; McCool WS
    J Lipid Res; 2019 Mar; 60(3):464-474. PubMed ID: 30692142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer cells - Proliferation, survival and invasion by lysophosphatidic acid.
    Lee SJ; Yun CC
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1907-10. PubMed ID: 20932934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
    Willier S; Butt E; Grunewald TG
    Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox.
    Llona-Minguez S; Ghassemian A; Helleday T
    Prog Lipid Res; 2015 Apr; 58():51-75. PubMed ID: 25704399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.